Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Ernström & C:o
Mandate

Vinge advised Ernström & C:o

December 02, 2017 M&A

Vinge has advised Ernström & C:o in conjunction with the investment and acquisition of shares in CellMark Investment.

Ernström is a Gothenburg-based investment company which is owned by the Hobohm Hielte family. CellMark is a global trading house within chemicals, paper, pulp, metals, packaging, recycling, energy and pharmaceuticals. Ernström has acquired almost one quarter of CellMark.

Vinge’s team consisted of responsible partner Olof Jisland together with associates Filip Öhrner, Daniel Lennartsson, André Isacson, Sara Strandberg, Filip Markhed and VDR assistant Sofie Sundin.

Related

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025